Long-acting reversible contraceptive (LARCs) methods
- PMID: 32014434
- DOI: 10.1016/j.bpobgyn.2019.12.002
Long-acting reversible contraceptive (LARCs) methods
Abstract
Unplanned pregnancy (UP) is a public health problem, which affects millions of women worldwide. Providing long-acting reversible contraceptive (LARC) methods is an excellent strategy to avoid or at least reduce UP, because the effectiveness of these methods is higher than other methods, and is indeed comparable to that of permanent contraception. As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companies have introduced a copper IUD (Cu-IUD), different models of levonorgestrel-releasing intrauterine system (LNG IUS), and one and two-rod implants, which certainly improved women's LARC options. The main characteristic of LARCs is that they provide high contraceptive effectiveness with a single intervention, and that they can be used for a long time. Emerging evidence from the last few years has demonstrated that it is possible to extend the use of the 52 mg LNG IUS and of the etonogestrel-implant beyond five- and three years, respectively, which adds new value to these LARCs.
Keywords: Contraception; Copper intrauterine device; LARCs; Levonorgestrel-releasing intrauterine system; Long acting contraceptives; Subdermal implants.
Copyright © 2019. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest LB and IM have received honoraria as members of advisory boards and have been invited as speakers at scientific meetings for Bayer Healthcare Pharmaceuticals and Merck. None of the other authors have any conflicts of interest to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials